Volume 23, Number 6—June 2017
Dispatch
Seoul Virus Infection in Humans, France, 2014–2016
Table 2
Patient no. | Day of sampling† | First-line diagnostic test, commercial ELISA (index value) |
Diagnostic confirmation at NRC |
Additional test at NRC‡ |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ELISA |
IFA |
||||||||||||
IgM |
IgG |
Ig |
IgM |
||||||||||
IgM | IgG | SEOV | PUUV | SEOV | PUUV | SEOV | PUUV | PUUV | |||||
1 | 3 | +§ (4.3) | +§ (1.9) | + | – | – | – | – | – | – | |||
2 | 5 | +¶ (7.9) | +¶ (>200) | + | – | E | – | + | E | – | |||
29 | ND | ND | + | E | + | E | + | – | ND | ||||
3 | 4 | +§ (11.8) | +§ (9.8) | + | + | E | – | + | – | – | |||
80 | ND | ND | + | – | + | + | + | + | ND |
*E, equivocal; IFA, indirect fluorescent antibody; ND, not done; NRC, National Reference Center for Hantavirus (Lyon, France); PUUV, Puumala virus, SEOV, Seoul virus; +, positive; –, negative.
†No. days after symptom onset.
‡Reascan Rapid Test (Reagena, Toivala, Finland).
§Hantavirus IgG DxSelect and Hantavirus IgM DxSelect (Focus Diagnostics, Cypress, CA, USA).
¶Hantavirus Pool 1 Eurasia IgG and IgM (Euroimmun AG, Lübeck, Germany).
Page created: May 16, 2017
Page updated: May 16, 2017
Page reviewed: May 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.